Domestic pharmaceutical firms will likely lose momentum under proposed quantity-price linkage system
Published: 2006-11-02 07:00:00
Updated: 2006-11-02 07:00:00
The government's plan to introduce a system of linking the quantity and quantity of drugs in evaluating drugs to be covered by national insurance will result in discouraging local pharmaceutical firms' will to develop new drugs due to more uncertain business prospect, according to the Korea Pharm...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
